Perioperative GLP-1 therapy in patients suffering from obesity undergoing arthroplasty is associated with moderate-certainty evidence of reduced PJI after THA and 90-day readmissions, with low-certainty evidence showing no clear effect on TKA-PJI or revision. This evidence concerns the gene GLP1R and Obesity.